Swine flu anxiety got you down? Well you can chin up a little as the FDA approved its first batches of swine flu vaccines developed by four pharmaceutical companies, ensuring that there will be enough to reach Americans who seek H1N1 vaccine protection.
The U.S. has put in an order for 195 million doses of H1N1 vaccine which is projected to be enough for the country’s 300 million-strong population. Though the numbers don’t seem to add up, the U.S. Center for Disease Control and Prevention (CDC) notes that millions of flu vaccines are discarded on an annual basis after flu season. Since the H1N1 vaccine is not mandatory for all people, the CDC is confident that the doses ordered will fulfill the nation’s needs.
The U.S.–along with Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland, and Great Britain–has agreed to pass on 10% of its H1N1 vaccine to countries that would otherwise not have access to it.
Before the flu season finds your personal IP address, you should consider whether or not you will seek the H1N1 vaccine. And then be on the lookout for the vaccine’s availability sometime in October.
Related Resources:
- U.S. approves H1N1 vaccine, says enough for everyone (Reuters)
- US, Europe offer swine flu vaccine to nations in need (AFP)
- US to share 10 percent swine flu vaccine globally (AP)
- UPDATE 1-Rich countries to share some swine flu vaccine (Reuters)
You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help
Civil Rights
Block on Trump’s Asylum Ban Upheld by Supreme Court
Criminal
Judges Can Release Secret Grand Jury Records
Politicians Can’t Block Voters on Facebook, Court Rules
